A practical reference on albumin binding: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-10 and is reviewed periodically as new material appears.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
| Property | Value | Notes |
|---|---|---|
| Chemical class | GLP-1 receptor agonist peptide | Mimics endogenous incretin signaling |
| Molecular mass | Approximately 4114 Da | Modified 31-amino-acid backbone |
| Appearance | White to off-white powder | Typical of lyophilized peptide material |
| Solubility | Soluble in water | Behavior depends on salt form and buffer |
| Elimination half-life | About one week | Supported by albumin binding and protease resistance |
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
== Upholstery filling == Buckwheat hulls are used as filling for a variety of upholstered goods, including pillows. The hulls are durable and do not insulate or reflect heat as much as synthetic filling. They are sometimes marketed as an alternative natural filling to feathers for those allergic to feathers. However, medical studies to measure the health effects of pillows manufactured with unprocessed and uncleaned hulls concluded that such pillows contain higher levels of a potential allergen that may trigger asthma in susceptible individuals than do synthetic-filled pillows.
Arsène Wenger management career statistics at Soccerbase Arsène Wenger manager profile at J.League (archive) (in Japanese) Arsène Wenger profile at Arsenal.com Arsène Wenger at Soccerway.com Arsène Wenger at WorldFootball.net Arsène Wenger at Soccerbase.com (manager) Arsène Wenger at J.League (manager) (in Japanese) Arsène Wenger at L'Équipe (in French)
== Impact == According to the United Nations Office for the Coordination of Humanitarian Affairs (OCHA), the civilian infrastructure in Eastern Afghanistan suffered as a result of hostilities. As of late April 2026, about 19 health facilities were closed, suspended or operating at reduced capacity. About 78,000 people suffered from limited access to healthcare as a consequence. Education services also faced disruptions with more than 13,000 students affected in Kunar and Nangarhar provinces. Water systems were damaged in at least six villages. Between late February and late April, approximately 100,900 people were displaced across Khost, Kunar, Nangarhar, Nuristan, Paktia, and Paktika provinces. Continuous shelling and unexploded ordnances constrained access for humanitarian operations in some of these provinces. Death counts, especially the toll on civilians, remained disputed during the course of the conflict. While the Taliban claimed 800 Afghan civilians were killed by April, Pakistan claimed that its forces killed over 640 militants and 850 'facilitators.' According to Azizullah Aziz, a journalist and eastern zone coordinator of the Afghan Journalists Safety Committee, most of the attacks were carried out "at night, during Ramadan." Amid the conflict, the deportation of Afghans from Pakistan continued. According to the International Organization for Migration (IOM) in Kandahar, while the deportations through the Torkham crossing paused in March, repatriations continued through the Spin Boldak crossing.
Sources: en.wikipedia.org
This is a bibliography of works by Oscar Wilde (1854–1900), a late-Victorian Irish writer. Chiefly remembered today as a playwright, especially for The Importance of Being Earnest, and as the author of The Picture of Dorian Gray; Wilde's oeuvre includes criticism, poetry, children's fiction, and a large selection of reviews, lectures and journalism. His private correspondence has also been published. Wilde was declared bankrupt to pay legal costs after his conviction for "gross indecency," and his possessions – including manuscripts, letters, books and presentation volumes of all the major literary figures of his day – were sold by auction. This has made bibliographical (and biographical) studies of unpublished work more difficult since they are widely dispersed, some in private ownership. The largest collection of Wilde's letters, manuscripts, and other material relating to his literary circle are housed at the William Andrews Clark Memorial Library. A number of Wilde's letters and manuscripts can also be found at the British Library, as well as public and private collections throughout Britain, the United States and France.
== Demographics == The homeland was set up to house Setswana-speaking peoples. In 1983, it had more than 1,430,000 inhabitants; in 1990, it had an estimated population of 2,352,296. Only 10% of Bophuthatswana's total land area was arable, and much of that was covered with scrub bush. Though the majority of its population was Tswana-speaking, Tswana, English, and Afrikaans were all designated as official languages by the Constitution of Bophuthatswana.
"Clypeasteroida". Integrated Taxonomic Information System. Mooi, Rich (1990). "Paedomorphosis, Aristotle's lantern, and the origin of the sand dollars (Echinodermata: Clypeasteroida)". Paleobiology. 16 (1): 25–48. Bibcode:1990Pbio...16...25M. doi:10.1017/S0094837300009714. JSTOR 2400931. Ellers, Olaf; Telford, Malcolm (22 October 1997). "Muscles advance the teeth in sand dollars and other sea urchins". Proceedings of the Royal Society of London. Series B: Biological Sciences. 264 (1387): 1525–1530. doi:10.1098/rspb.1997.0211. PMC 1688700. Stock, Stuart R. (January 2014). "Sea urchins have teeth? A review of their microstructure, biomineralization, development and mechanical properties". Connective Tissue Research. 55 (1): 41–51. doi:10.3109/03008207.2013.867338. PMC 4727832. PMID 24437604. The Common Sand Dollar by Cheryl Page Video showing the life cycle of Clypeaster subdepressus
They feature multiply charged ions alkali metal adducts and non covalent complexes that originate from the condensed phase of the sample/solvent interaction. DESI is revealed to have a more gentle ionization condition that leads to a more pronounced tendency for metal adduct formation and a lower specific charging of secondary droplets.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and cleared quickly. Semaglutide carries a position 8 substitution that blocks that cleavage and a fatty diacid chain that binds albumin. Together these changes extend its circulating half-life to about one week.
Yes. Stimulation of insulin secretion is glucose-dependent, meaning the effect is larger when blood glucose is high and minimal when it is normal. This property separates GLP-1 receptor agonists from agents that drive insulin release regardless of glucose level.
Receptor expression in hypothalamic and brainstem regions is well documented, and reduced energy intake is consistently observed. The relative contribution of central versus peripheral signaling to total weight change is still an open question addressed by ongoing research.
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.